Literature DB >> 9759897

A complex element regulates IFN-gamma-stimulated monocyte chemoattractant protein-1 gene transcription.

A J Valente1, J F Xie, M A Abramova, U O Wenzel, H E Abboud, D T Graves.   

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is induced in chronic osseous inflammation, and is temporally and spatially correlated with monocyte recruitment. We investigated the mechanism of MCP-1 regulation in a human osteoblastic cell line in response to IFN-gamma, a potent mediator of the immune inflammatory response. Nuclear run-on and stability studies demonstrated that IFN-gamma stimulated MCP-1 transcription and did not enhance mRNA stabilization. Using MCP-1 promoter/reporter gene constructs, we determined that IFN-gamma-enhanced MCP-1 transcription is regulated by a 29-bp element located at -227 relative to the ATG start codon. This element contains a 13-bp CT-rich sequence (GCTTCCCTTTCCT) adjacent to a IFN-gamma activation site (GAS). Since deletion of the CT sequence enhanced both the magnitude and duration of IFN-gamma-stimulated, GAS-mediated transcription, we have termed it the IFN response-inhibitory sequence (IRIS). The combined IRIS/GAS sequence is highly conserved in mouse, rat, and bovine MCP-1 genes. In gel-shift assays, nuclear extracts from IFN-gamma-stimulated osteoblastic cells formed two specific inducible bands with labeled IRIS/GAS DNA. Both bands were supershifted by anti-STAT1 Abs, but not by Abs to STAT2, p48(ISGF-3y), IFN-regulatory factor-1, or IFN-regulatory factor-2. Formation of one of the bands required the presence of the IRIS moiety. IRIS/GAS DNA also formed a number of specific complexes with constitutively expressed factors, none of which were affected by the above Abs. These studies establish a mechanism for IFN-gamma-stimulated MCP-1 expression and identify a complex element that regulates MCP-1 gene transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759897

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.

Authors:  N Marx; F Mach; A Sauty; J H Leung; M N Sarafi; R M Ransohoff; P Libby; J Plutzky; A D Luster
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

2.  Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia.

Authors:  Matthew R Jones; Lee J Quinton; Benjamin T Simms; Michal M Lupa; Mariya S Kogan; Joseph P Mizgerd
Journal:  J Infect Dis       Date:  2005-12-27       Impact factor: 5.226

3.  Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB.

Authors:  N Mori; A Ueda; R Geleziunas; A Wada; T Hirayama; T Yoshimura; N Yamamoto
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  The innate immune response following multivalent dengue vaccination and implications for protection against dengue challenge.

Authors:  Ruixue Hou; Lewis E Tomalin; Jessica Pintado Silva; Seunghee Kim-Schulze; Stephen S Whitehead; Ana Fernandez-Sesma; Anna P Durbin; Mayte Suárez-Fariñas
Journal:  JCI Insight       Date:  2022-06-08

Review 5.  The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

Authors:  Teizo Yoshimura
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

6.  Interferon-γ: Promising therapeutic target in atherosclerosis.

Authors:  Joe We Moss; Dipak P Ramji
Journal:  World J Exp Med       Date:  2015-08-20

7.  Immunization enhances inflammation and tissue destruction in response to Porphyromonas gingivalis.

Authors:  Cataldo W Leone; Haneen Bokhadhoor; David Kuo; Tesfahun Desta; Julia Yang; Michelle F Siqueira; Salomon Amar; Dana T Graves
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner.

Authors:  Derek Strassheim; Suzzette R Riddle; Danielle L Burke; Mark W Geraci; Kurt R Stenmark
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 9.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

10.  Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C.

Authors:  Carol Murray; Éadaoin W Griffin; Elaine O'Loughlin; Aoife Lyons; Eoin Sherwin; Suaad Ahmed; Nigel J Stevenson; Andrew Harkin; Colm Cunningham
Journal:  Brain Behav Immun       Date:  2015-04-18       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.